Characteristic | N o. of patients | % |
---|---|---|
Patients evaluable | 41 | 100 |
Age, years | Â | Â |
Median | 60 | / |
Range | 32-75 | Â |
ECOG PS | Â | Â |
0 | 13 | 32 |
1 | 21 | 51 |
2 | 7 | 17 |
Tumor histology/citology | Â | Â |
Serous adenocarcinoma | 10 | 24.5 |
Adenocarcinoma | 7 | 17 |
Papillary serous | 6 | 15 |
Clear cell adenocarcinoma | 2 | 5 |
Endometrioid | 3 | 7 |
Mucinous adenocarcinoma | 3 | 7 |
Poorly differentiated | 10 | 24.5 |
Stage at diagnosis | Â | Â |
I,II | 2 | 5 |
III (A, B, C) | 33 (10, 12, 11) | 80 |
IV | 6 | 15 |
N of prior chemotherapy regimens | Â | Â |
1 | 3 | 7 |
2 | 12 | 29 |
≥3 | 26 | 64 |
N of prior platinum-based regimens | Â | Â |
1 | 23 | 56 |
2 | 9 | 22 |
3 | 9 | 22 |